PRNewsWire
28 Oct 2026, 02:25 UTC · 1h ago
TENX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Tenax Therapeutics, Inc.
Impact · against what's priced in
The reminder of a lead plaintiff deadline for the class action lawsuit against Tenax Therapeutics is a minor procedural update. The catastrophic 89.77% share price collapse already accounts for the Phase 3 trial failure and the existence of the litigation.
- TENX−0.10
No priced-in read yet





